Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial…

Organigram Reports Third Quarter Fiscal 2025 Results

TORONTO — Organigram Global Inc. reported results for the third quarter ended June 30, 2025 (“Q3 Fiscal 2025” or “Q3”). Q3 fiscal 2025 highlights Record Gross Revenue: $110.2 million (+73% year-over-year, +7.2% sequential). Record Net Revenue: $70.8 million (+72% year-over-year, +7.9% sequential). International Revenue: $7.4 million (+208% year-over-year, +21% sequential). Adjusted EBITDA: $5.7 million (+64% year-over-year, +16% sequential). Fr…